Astragalus mongholicus Bunge and Panax notoginseng (Burkill) F.H. Chen Formula for Renal Injury in Diabetic Nephropathy—In Vivo and In Vitro Evidence for Autophagy Regulation
Open Access
- 12 June 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 732
- https://doi.org/10.3389/fphar.2020.00732
Abstract
Background: Diabetic nephropathy (DN) is a serious complication of diabetes mellitus (DM) with limited treatment options. DN leads to progressive renal failure and accelerates rapidly into end-stage renal disease. Astragalus mongholicus Bunge and Panax notoginseng (Burkill) F.H. Chen formula (APF) is a traditional Chinese medicine (TCM) formula widely used to treat chronic kidney diseases (CKD) in the clinic in the southwest of China. The aim of this study is to explore how APF and its related TCM theory work on DN and whether mTOR/PINK1/Parkin signaling plays a part in this process. Methods: HPLC was used for preliminary chemical analysis and quantitative analysis of the five components of APF. An in vivo autophagy deficiency model was established in C57BL/6 mice by streptozocin (STZ) combined with a high-fat and high-sugar diet, while the in vitro autophagy deficiency model was induced with high glucose (HG) in renal mesangial cells (RMCs). Renal histopathology staining was performed to investigate the extents of inflammation and injury. Real time-PCR and Western blotting techniques were utilized to assess autophagy-related proteins. Results: APF significantly ameliorated renal injury in DN mice, specifically restoring blood urea nitrogen, serum creatinine, and 24-hour albuminuria. APF also reduced the mRNA and protein expressions of TNFα, IL-1β, and IL-6 in STZ-induced DN mice. Furthermore, APF improved the autophagy deficiency induced by STZ in vivo or HG in vitro, as revealed by changes in the expressions of mTOR, PINK1, Parkin, Beclin 1, p62, and LC3B. Notably, inhibition of autophagy with 3-methyladenine in APF-treated RMCs aggravated cellular damage and altered mTOR/PINK1/Parkin signaling, indicating that APF rescued HG damage through promoting autophagy. Conclusion: APF may protect the kidneys from inflammation injuries in DN by upregulating autophagy via suppressing mTOR and activating PINK1/Parkin signaling. This experimental evidence strongly supports APF as a potential option for the prevention and treatment of DN.Keywords
This publication has 48 references indexed in Scilit:
- Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66 ShcProceedings of the National Academy of Sciences of the United States of America, 2012
- Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study GroupDiabetology & Metabolic Syndrome, 2012
- Hyperglycemia and Renin-Dependent Hypertension Synergize to Model Diabetic NephropathyJournal of the American Society of Nephrology, 2012
- Autophagy: Renovation of Cells and TissuesCell, 2011
- The Role of Atg Proteins in Autophagosome FormationAnnual Review of Cell and Developmental Biology, 2011
- Role of mTOR in podocyte function and diabetic nephropathy in humans and miceJCI Insight, 2011
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathyNature Reviews Nephrology, 2011
- Hypolipidemic and antioxidant activities of Sanchi (Radix Notoginseng) in rats fed with a high fat dietPhytomedicine, 2011
- Effect of total flavonoid fraction of Astragalus complanatus R.Brown on angiotensin II-induced portal-vein contraction in hypertensive ratsPhytomedicine, 2008
- Oxidative Stress as a Major Culprit in Kidney Disease in DiabetesDiabetes, 2008